Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF ONCOLOGY
Volume 43, Issue 5, Pages 1503-1510
Publisher
Spandidos Publications
Online
2013-08-23
DOI
10.3892/ijo.2013.2077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin: Multi-faceted protection against cancer
- (2015) Sonia Del Barco et al. Oncotarget
- Metformin and Hepatic Carcinogenesis
- (2012) M. Pollak et al. Cancer Prevention Research
- Cancer cell senescence: a new frontier in drug development
- (2012) Claire J. Cairney et al. DRUG DISCOVERY TODAY
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma
- (2012) Zhan Qu et al. HEPATOLOGY RESEARCH
- Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2012) Zhi-Jiang Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Enhanced cytotoxic effect of low doses of metformin combined with ionizing radiation on hepatoma cells via ATP deprivation and inhibition of DNA repair
- (2012) JIFANG LIU et al. ONCOLOGY REPORTS
- Senescence: a new weapon for cancer therapy
- (2012) Juan Carlos Acosta et al. TRENDS IN CELL BIOLOGY
- AMPK induces vascular smooth muscle cell senescence via LKB1 dependent pathway
- (2011) Jin Young Sung et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
- (2011) Tae-Won Kang et al. NATURE
- Metformin and neoplasia: Implications and indications
- (2011) Ahmad Aljada et al. PHARMACOLOGY & THERAPEUTICS
- SIRT1 Promotes Proliferation and Prevents Senescence Through Targeting LKB1 in Primary Porcine Aortic Endothelial Cells
- (2010) Yi Zu et al. CIRCULATION RESEARCH
- SIRT1 and AMPK in regulating mammalian senescence: A critical review and a working model
- (2010) Yu Wang et al. FEBS LETTERS
- The essence of senescence
- (2010) T. Kuilman et al. GENES & DEVELOPMENT
- Therapy-Induced Senescence in Cancer
- (2010) Jonathan A. Ewald et al. JNCI-Journal of the National Cancer Institute
- Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo
- (2009) Florence Debacq-Chainiaux et al. Nature Protocols
- Premature aging in mice activates a systemic metabolic response involving autophagy induction
- (2008) Guillermo Mariño et al. HUMAN MOLECULAR GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started